❮ Back to Researchers

Veronique Miron

PhD

Scientist, Keenan Research Centre for Biomedical Science

Email: veronique.miron@unityhealth.to
Twitter: @MironLab

Research Programs

Labs

Miron Lab ❯

Biography

Dr. Miron is the John David Eaton Chair in Multiple Sclerosis Research at the BARLO Multiple Sclerosis Centre and Keenan Research Centre for Biomedical Science, and Full Professor in the Department of Immunology at The University of Toronto. Her team aims to identify novel treatment strategies for neurological conditions in which there is damage to myelin – the insulation surrounding nerve fibres required for their health and function, including multiple sclerosis, Alzheimer’s disease, cerebral palsy, and normal ageing. The focus of the lab is to harness the regenerative properties of immune cells and inflammation to support myelin health across the lifespan. She has won several prestigious awards such as the Medical Research Council Senior Research Award, Medical Research Council Career Development Award, the London Institute of Medical Sciences Suffrage Science Award, and the European Charcot Foundation Young Investigator Award. She is an avid champion of gender equality in research and has put in place several initiatives to improve equality and diversity practices both locally and internationally.

Recent Publications

  1. Monteiro, JK, Miron, VE. Microglia conduct the symphony of white matter degeneration in aging through T cell recruitment. Nat Neurosci. 2025;28 (6):1116-1117. doi: 10.1038/s41593-025-01929-y. PubMed PMID:40404996 .
  2. Hill, BM, Holloway, RK, Forbes, LH, Davies, CL, Monteiro, JK, Brown, CM et al.. Monocyte-secreted Wnt reduces the efficiency of central nervous system remyelination. PLoS Biol. 2025;23 (4):e3003073. doi: 10.1371/journal.pbio.3003073. PubMed PMID:40233100 PubMed Central PMC12052099.
  3. Vanherle, S, Loix, M, Miron, VE, Hendriks, JJA, Bogie, JFJ. Lipid metabolism, remodelling and intercellular transfer in the CNS. Nat Rev Neurosci. 2025;26 (4):214-231. doi: 10.1038/s41583-025-00908-3. PubMed PMID:39972160 .
  4. Edmondson-Stait, AJ, Davyson, E, Shen, X, Adams, MJ, Khandaker, GM, Miron, VE et al.. Associations between IL-6 and trajectories of depressive symptoms across the life course: Evidence from ALSPAC and UK Biobank cohorts. Eur Psychiatry. 2025;68 (1):e27. doi: 10.1192/j.eurpsy.2025.7. PubMed PMID:39865800 PubMed Central PMC11883784.
  5. Smith, KJ, Lim, Z, Vermeren, S, Miron, VE, Dimeloe, S, Davidson, DJ et al.. Proteomic analysis reveals dysregulation of peripheral blood neutrophils in patients with Multiple Sclerosis. Clin Exp Immunol. 2025;219 (1):. doi: 10.1093/cei/uxae115. PubMed PMID:39817476 PubMed Central PMC12124191.
  6. Ontaneda, D, Miron, VE. Breaking Barriers in Multiple Sclerosis. Mult Scler. 2024;30 (5_suppl):3-4. doi: 10.1177/13524585241292945. PubMed PMID:39658898 .
  7. Hoffmann, A, Miron, VE. CNS macrophage contributions to myelin health. Immunol Rev. 2024;327 (1):53-70. doi: 10.1111/imr.13416. PubMed PMID:39484853 .
  8. Kalia, LV, Asis, A, Arbour, N, Bar-Or, A, Bove, R, Di Luca, DG et al.. Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis. Nat Rev Neurol. 2024;20 (12):724-737. doi: 10.1038/s41582-024-01023-0. PubMed PMID:39375563 .
  9. Craig, GA, Ryan, L, Thapar, J, McNamara, NB, Hoffmann, A, Page, D et al.. Reflective imaging of myelin integrity in the human and mouse central nervous systems. Front Cell Neurosci. 2024;18 :1408182. doi: 10.3389/fncel.2024.1408182. PubMed PMID:39049821 PubMed Central PMC11266064.
  10. McNamara, NB, Munro, DAD, Bestard-Cuche, N, Uyeda, A, Bogie, JFJ, Hoffmann, A et al.. Author Correction: Microglia regulate central nervous system myelin growth and integrity. Nature. 2024;631 (8021):E11. doi: 10.1038/s41586-024-07696-3. PubMed PMID:38961305 PubMed Central PMC11254745.
Search PubMed

Affiliations & Other Activities

  • Professor, Department of Immunology, University of Toronto